CENCORA INC (ABG.DE) Stock Price & Overview

FRA:ABG • US03073E1055

Current stock price

304.15 EUR
-5.95 (-1.92%)
Last:

The current stock price of ABG.DE is 304.15 EUR. Today ABG.DE is down by -1.92%. In the past month the price increased by 2.86%.

ABG.DE Key Statistics

1-Month Range284 - 321.5
Current ABG.DE stock price positioned within its 1-month range.
Market Cap
59.166B
P/E
21.51
Fwd P/E
17.67
EPS (TTM)
14.14
Dividend Yield
0.72%

ABG.DE Stock Performance

Today
-1.92%
1 Week
-2.86%
1 Month
+2.86%
3 Months
-5.66%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ABG.DE Stock Chart

CENCORA INC / ABG Daily stock chart

ABG.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ABG.DE.


Chartmill TA Rating
Chartmill Setup Rating

ABG.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE. ABG.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABG.DE Earnings

On February 4, 2026 ABG.DE reported an EPS of 4.08 and a revenue of 85.93B. The company beat EPS expectations (0.03% surprise) and missed revenue expectations (-1.1% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 4, 2026
PeriodQ1 / 2026
EPS Reported$4.08
Revenue Reported85.932B
EPS Surprise 0.03%
Revenue Surprise -1.10%

ABG.DE Forecast & Estimates

22 analysts have analysed ABG.DE and the average price target is 332.07 EUR. This implies a price increase of 9.18% is expected in the next year compared to the current price of 304.15.

For the next year, analysts expect an EPS growth of 11.29% and a revenue growth 7.93% for ABG.DE


Analysts
Analysts82.73
Price Target332.07 (9.18%)
EPS Next Y11.29%
Revenue Next Year7.93%

ABG.DE Groups

Sector & Classification

Index Membership

ABG.DE Financial Highlights

Over the last trailing twelve months ABG.DE reported a non-GAAP Earnings per Share(EPS) of 14.14. The EPS increased by 14.99% compared to the year before.


Income Statements
Revenue(TTM)325.78B
Net Income(TTM)1.63B
Industry RankSector Rank
PM (TTM) 0.5%
ROA 2.07%
ROE 85.16%
Debt/Equity 3.97
Chartmill High Growth Momentum
EPS Q2Q%9.38%
Sales Q2Q%5.45%
EPS 1Y (TTM)14.99%
Revenue 1Y (TTM)7.45%

ABG.DE Ownership

Ownership
Inst Owners96.15%
Shares194.53M
Float186.27M
Ins Owners0.09%
Short Float %N/A
Short RatioN/A

About ABG.DE

Company Profile

ABG logo image Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Company Info

IPO: 1996-05-28

CENCORA INC

1 West First Avenue

Conshohocken PENNSYLVANIA US

Employees: 44000

ABG Company Website

ABG Investor Relations

Phone: 13026587581

CENCORA INC / ABG.DE FAQ

What does ABG do?

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.


What is the current price of ABG stock?

The current stock price of ABG.DE is 304.15 EUR. The price decreased by -1.92% in the last trading session.


Does ABG stock pay dividends?

CENCORA INC (ABG.DE) has a dividend yield of 0.72%. The yearly dividend amount is currently 1.95.


How is the ChartMill rating for CENCORA INC?

ABG.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the market expecting ABG stock to perform?

22 analysts have analysed ABG.DE and the average price target is 332.07 EUR. This implies a price increase of 9.18% is expected in the next year compared to the current price of 304.15.


What is the expected growth for ABG stock?

The Revenue of CENCORA INC (ABG.DE) is expected to grow by 7.93% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Who owns CENCORA INC?

You can find the ownership structure of CENCORA INC (ABG.DE) on the Ownership tab.